buthionine sulfoximine has been researched along with Bladder Cancer in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 8 (53.33) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, LC; Dia, YC; Jou, YC; Liu, YW; Shen, CH; Wang, SC; Wang, ST; Yang, HY; Yu, MH | 1 |
| Chen, J; Guan, JY; Hour, TC; Huang, CY; Lu, SH; Pu, YS | 2 |
| Hampton, MB; King, MJ; Midwinter, RG; Pullar, JM; Thomson, SJ; Turnbull, CI | 1 |
| Backes, MG; Blanock, K; Emerson, EO; Jani, JP; Rihn, C; Scalamogna, D; Singh, SV; Specht, S; Stemmler, N; Xu, BH | 1 |
| Chow, S; Hedley, DW | 1 |
| Gupta, V; Singh, SV; Xu, BH | 1 |
| Benson, PJ; Gupta, V; Hu, X; Pinto, T; Singh, S; Xia, H; Zaren, HA | 1 |
| Miyajima, A; Murai, M; Nakashima, J; Tachibana, M; Tazaki, H; Yoshioka, K | 1 |
| Kamei, H | 1 |
| Alken, P; Köhrmann, KU; Marx, C; Rassweiler, J; Schummer, B; Seemann, O; Siegsmund, MJ; Steidler, A; Toktomambetova, L | 1 |
| Bachor, R; Hasan, T; Scholz, M; Shea, CR | 1 |
| Cockett, AT; Lee, KE; Mayer, RD | 2 |
| Astor, M; Tomashefsky, P; White, RD | 1 |
15 other study(ies) available for buthionine sulfoximine and Bladder Cancer
| Article | Year |
|---|---|
Anti-Cancer Effects and Tumor Marker Role of Glutathione
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Buthionine Sulfoximine; Cell Adhesion; Cell Death; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cisplatin; DNA Methylation; Down-Regulation; Doxorubicin; Female; Gene Expression Regulation, Neoplastic; Glutathione; Glutathione Transferase; Humans; Male; Middle Aged; Mitomycin; Promoter Regions, Genetic; RNA, Messenger; Sex Characteristics; Urinary Bladder Neoplasms | 2021 |
Cytotoxicity of arsenic trioxide to transitional carcinoma cells.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Carcinoma, Transitional Cell; Cisplatin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Glutathione; Humans; Oxides; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2002 |
The chemopreventive agent phenethyl isothiocyanate sensitizes cells to Fas-mediated apoptosis.
Topics: Aldehyde Dehydrogenase; Anticarcinogenic Agents; Apoptosis; Buthionine Sulfoximine; Caspase 3; Caspases; Chemoprevention; Drug Resistance, Neoplasm; fas Receptor; Humans; Isothiocyanates; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Urinary Bladder Neoplasms | 2004 |
Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line.
Topics: Antimetabolites, Antineoplastic; Biological Transport; Buthionine Sulfoximine; Cadmium; Cadmium Chloride; Carboplatin; Cell Line; Cell Survival; Chlorides; Cisplatin; Drug Resistance; Gene Expression; Glutathione; Glutathione Transferase; Humans; Isoenzymes; Kinetics; Metallothionein; Methionine Sulfoximine; Mitomycin; RNA, Messenger; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1995 |
Evaluation of methods for measuring cellular glutathione content using flow cytometry.
Topics: Animals; Breast Neoplasms; Bridged Bicyclo Compounds; Buthionine Sulfoximine; Carcinoma; Carcinosarcoma; CHO Cells; Colonic Neoplasms; Cricetinae; Ethylmaleimide; Eukaryotic Cells; Evaluation Studies as Topic; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Glutathione; Humans; Maleates; Mammary Neoplasms, Experimental; Methionine Sulfoximine; Mice; o-Phthalaldehyde; Phenylmercury Compounds; Pyrazoles; Species Specificity; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1994 |
Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
Topics: Antimetabolites, Antineoplastic; Buthionine Sulfoximine; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance; Ethacrynic Acid; Glutathione; Glutathione Transferase; Humans; Isoenzymes; Kinetics; Methionine Sulfoximine; Mitomycin; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1994 |
Lack of a role of glutathione in cellular nonenzymatic activation of BMS-181174, a novel analogue of mitomycin C.
Topics: Antineoplastic Agents, Alkylating; Biotransformation; Buthionine Sulfoximine; Cysteine; Enzyme Inhibitors; Glutamate-Cysteine Ligase; Glutathione; Humans; Methionine Sulfoximine; Mitomycin; Mitomycins; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1996 |
Role of reactive oxygen species in cis-dichlorodiammineplatinum-induced cytotoxicity on bladder cancer cells.
Topics: Antimetabolites; Antineoplastic Agents; Buthionine Sulfoximine; Carcinoma, Transitional Cell; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Fluoresceins; Glutathione; Humans; Hydrogen Peroxide; Maleates; Reactive Oxygen Species; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1997 |
Cystine starvation induces reversible large-body formation from nuclear bodies in T24 cells.
Topics: Amino Acids; Antigens, Nuclear; Autoantigens; Buthionine Sulfoximine; Cell Nucleus; Cystine; Humans; Microscopy, Electron; Microscopy, Immunoelectron; Neoplasm Proteins; Nuclear Proteins; Promyelocytic Leukemia Protein; Sulfhydryl Reagents; Transcription Factors; Tumor Cells, Cultured; Tumor Suppressor Proteins; Urinary Bladder Neoplasms | 1997 |
Cisplatin-resistant bladder carcinoma cells: enhanced expression of metallothioneins.
Topics: Antineoplastic Agents; Buthionine Sulfoximine; Cadmium; Carcinoma, Transitional Cell; Cell Division; Cisplatin; Doxorubicin; Drug Resistance; Drug Resistance, Multiple; Glutathione; Humans; Metallothionein; Methotrexate; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Vinblastine | 1999 |
Arsenic trioxide as a novel anticancer agent against human transitional carcinoma--characterizing its apoptotic pathway.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Carcinoma, Transitional Cell; Caspase 3; Caspases; Cisplatin; DNA, Neoplasm; Drug Resistance, Neoplasm; Enzyme Activation; G1 Phase; Humans; Membrane Potentials; Mitochondria; Oxides; Reactive Oxygen Species; Signal Transduction; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2002 |
Mechanism of photosensitization by microsphere-bound chlorin e6 in human bladder carcinoma cells.
Topics: Buthionine Sulfoximine; Cell Line; Cell Survival; Chlorophyllides; Fibroblasts; Humans; Kinetics; Light; Methionine Sulfoximine; Microspheres; Porphyrins; Radiation-Sensitizing Agents; Urinary Bladder Neoplasms | 1991 |
Effect of systemic glutathione depletion by buthionine sulfoximine on sensitivity of murine bladder cancer to cytotoxic agents.
Topics: Animals; Antimetabolites; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Buthionine Sulfoximine; Carcinoma, Transitional Cell; Female; Glutathione; Kidney; Liver; Lung; Methionine Sulfoximine; Mice; Mice, Inbred C3H; Myocardium; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1989 |
Inhibition of cisplatin-induced nephrotoxicity in rats by buthionine sulfoximine, a glutathione synthesis inhibitor.
Topics: Animals; Buthionine Sulfoximine; Carcinoma, Transitional Cell; Cisplatin; Female; gamma-Glutamyltransferase; Glutamate-Cysteine Ligase; Glutathione; Kidney; Kidney Diseases; Male; Methionine Sulfoximine; Mice; Mice, Inbred C3H; Rats; Rats, Inbred Strains; Time Factors; Urinary Bladder Neoplasms | 1987 |
Relationship between thiol depletion and chemosensitization in a transplantable murine bladder tumor.
Topics: Animals; Buthionine Sulfoximine; Carcinoma, Transitional Cell; Cyclophosphamide; Drug Combinations; Drug Resistance; Female; Glutathione; Liver; Maleates; Methionine Sulfoximine; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Urinary Bladder Neoplasms | 1985 |